Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes

Oncogene

Volumn 16, Issue 21, 1998, Pages 2711-2721

  Li, Jian Jian ^a   Rhim, Johng S ^a   Schlegel, Richard ^b   Vousden, Karen H ^a   Colburn, Nancy H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Dominant negative cJun; HPV; Transcription factor; Transformation: human keratinocytes

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR AP 1;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CARCINOGENICITY; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA TRANSFECTION; GENE MUTATION; HUMAN; HUMAN CELL; KERATINOCYTE; NUDE MOUSE; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; VIRUS CELL TRANSFORMATION; VIRUS ONCOGENE; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MUS MUSCULUS;

EID: 0032575007     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201798     Document Type: Article

References (49)

1. Angel A and Karin M. (1991). Biochim. Biophys. Acta. 1072, 129-157.
2. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P and Karin M. (1987). Cell, 49, 729-739.
3. Antinore MJ, Birrer MJ, Peter D, Nader L and McCance DJ. (1996). EMBO J., 15, 1950-1960.
4. Baeuerle PA and Henkel T. (1994). Annu. Rev. Immunol., 12, 141-179.
5. Baeuerle PA. (1991). Biochem. Biophys. Acta, 1072, 63-80.
6. Baeuerle PA and Baltimore D. (1996). Cell, 87, 13-20.
7. Beauparlant P, Kwan I, Bitar R, Chou P, Koromilas AE, Sonenberg N and Hiscott J. (1994). Oncogene, 9, 3189-3197.
8. Bernstein LR and Colburn NH. (1989). Science, 244, 566-569.
9. Brown PH, Chen TK and Birrer MJ. (1994). Oncogene, 9, 791-799.
10. Brown PH, Alani R, Preis LH, Szabo E and Birrer MJ. (1993). Oncogene, 8, 877-886.
11. Brown PH, Kim SH, Wise SC, Sabichi AL and Birrer MJ. (1996). Cell Growth & Diff., 7, 1013-1021.
12. Carroll R, Martarano L and Derse D. (1991). J. Virology, 65, 3460-3467.
13. Chen T-Z, Pecoraro G and Defendi V. (1993). Cancer Res., 53, 1167-1171.
14. Cheng J, Turksen K, Yu QC, Schreiber H, Teng M and Fuchs E. (1992). Genes Dev., 6, 1444-1456.
15. Colburn NH, Wendel E and Srinivas L. (1982). J. Cell. Biochem., 18, 261-270.
16. Colburn NH, Wendel E and Abruzzo G. (1981). Proc. Natl. Acad. Sci. USA, 78, 6912-6916.
17. Colburn NH, Former BF, Nelson KA and Yuspa SH. (1979). Nature, 281, 589-591.
18. Crook T, Marston NJ, Sara EA and Vousden KH. (1994). Cell, 79, 817-827.
19. Czegledy J, Evander M, Hernadi Z, Gergely L and Wadell G. (1994). Int. J. Cancer, 56, 182-186.
20. Dong Z, Birrer MJ, Watts RG, Matrisian LM and Colburn NH. (1994). Proc. Natl. Acad. Sci. USA, 91, 609-613.
21. Dong Z, Crawford HC, Lavrovsky V, Taub D, Matrisian LM and Colburn NH. (1997). Mol. Carcinogenesis, 19, 204-212.
22. Drinkwater NR. (1989). Genetic Control of Hepatocarcinogenesis in Inbred Mice. Colburn NH (ed). Dekker Press: New York, pp 3-17
23. Dyson N, Howley PM, Munger K and Harlow E. (1989). Science, 243, 934-937.
24. Fearon ER and Vogelstein B. (1990). Cell, 61, 759-767.
25. Greenhalgh DA, Wang XJ, Eckhardt JN and Roop DR. (1995). Cell Growth Different., 6, 579-586.
26. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR and Schiller JT. (1989). EMBO J., 8, 3905-3910.
27. Hurlin PJ, Kaur P, Smith PP, Perez-Reyes N, Blanton RA and McDougall JK. (1991). Proc. Natl. Acad. Sci. USA, 88, 570-574.
28. Joseloff E and Bowden GT. (1997). Mol. Carcinogenesis, 18, 26-36.
29. Kemp CJ, Burns PA, Brown K, Nagase H and Balmain A. (1994). Cold Spring Harb. Symp. Quant. Biol., 59, 427-434.
30. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW and Vogelstein B. (1992). Science, 256, 827-830.
31. Lee W, Haslinger A, Karin M and Tjian B. (1987). Nature, 325, 368-372.
32. Li J-J, Dong Z, Dawson MI and Colburn NH. (1996). Cancer Res., 56, 483-489.
33. Li J-J, Westergaard C, Ghosh P and Colburn NH. (1997). Cancer Res., 57, 3569-3576.
34. Li J-J, Oberley LW, St Clair D, Ridnour LA and Oberley TD. (1995). Oncogene, 10, 1989-2000.
35. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E and Howley PM. (1989a). EMBO J., 8, 4099-4105.
36. Munger K, Phelps WC, Bubb V, Howley PM and Schlegel R. (1989b). J. Virol., 63, 4417-4421.
37. Nolan GP and Baltimore D. (1992). Curr. Opin. Genet. Dev., 2, 211-220.
38. Pei XF, Meck JM, Greenhalgh D and Schlegel R. (1993). Virology, 196, 855-860.
39. Rosenberger SF and Bowden GT. (1996). Oncogene, 12, 2301-2308.
40. Schlegel R, Phelps WC, Zhang Y-L and Barbosa M. (1988). EMBO J., 7, 3181-3187.
41. Stein B, Baldwin AS Jr., Ballard DW, Greene WC, Angel P and Herrlich P. (1993). EMBO. J., 12, 3879-3891.
42. Stellmach V, Leask A and Fuchs E. (1991). Proc. Natl. Acad. Sci. USA, 88, 4582-4586.
43. Thanos D and Maniatis T. (1995). Cell, 80, 529-532.
44. Vassar R and Fuchs E. (1991). Genes Dev., 5, 714-727.
45. Watts R, Ben-Ari ET, Bernstein LR, Birrer MJ, Winterstein D, Wendel E and Colburn NH. (1995). Mol. Carcinogenesis, 13, 27-36.
46. Weinberg RA. (1989). Cancer Res., 49, 3713-3721.
47. Werness BA, Levine AJ and Howley PM. (1990). Science, 248, 76-79.
48. Wilding J, Vousden KH, Soutter WP, McCrea PD, Buono RD and Pignatelli M. (1996). Cancer Res., 56, 5285-5292.
49. Yamagata T, Mitani K, Ueno H, Kanda Y, Yazake Y and Hirai H. (1997). Mol. Cell. Biol., 17, 4272-4281.